HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Minimally invasive/focused parathyroidectomy in patients with negative sestamibi scan results.

AbstractOBJECTIVE:
To examine the feasibility of minimally invasive/focused parathyroidectomy in patients with primary hyperparathyroidism and negative results on preoperative sestamibi scanning.
DESIGN:
Retrospective review.
SETTING:
Hospital.
PATIENTS:
A total of 452 patients with primary hyperparathyroidism underwent parathyroidectomy between January 2005 and December 2009.
MAIN OUTCOME MEASURES:
Preoperative sestamibi scans were reviewed, and their influence on the surgical outcome was examined. Records of the intraoperative and postoperative findings were also reviewed.
RESULTS:
Seventy-seven patients (17.0%) were found to have negative results on preoperative sestamibi scans, and these patients formed our cohort study group. In this group, neck ultrasonography performed as an adjunct was able to preoperatively localize an area that was suggestive of a single adenoma in 61 patients (79.2%), 53 of whom were confirmed to have a single adenoma intraoperatively (sensitivity, 80.3%; specificity, 27.3%; positive predictive value, 86.9%; and negative predictive value, 18.8%). In total, 66 of 77 patients (85.7%) were confirmed to have a single adenoma at the time of surgery.
CONCLUSIONS:
Negative results on sestamibi scans should not be used as exclusion criteria for minimally invasive/focused parathyroidectomy in patients with primary hyperparathyroidism. In our study, 66 patients with negative results on preoperative scans were found to have a single adenoma and were surgically cured by minimally invasive/focused parathyroidectomy.
AuthorsEmad Kandil, Ahmed Jan Malazai, Saud Alrasheedi, Ralph P Tufano
JournalArchives of otolaryngology--head & neck surgery (Arch Otolaryngol Head Neck Surg) Vol. 138 Issue 3 Pg. 223-5 (Mar 2012) ISSN: 1538-361X [Electronic] United States
PMID22351855 (Publication Type: Journal Article)
Chemical References
  • Radiopharmaceuticals
  • Technetium Tc 99m Sestamibi
Topics
  • Female
  • Humans
  • Hyperparathyroidism, Primary (radionuclide imaging, surgery, ultrasonography)
  • Male
  • Middle Aged
  • Minimally Invasive Surgical Procedures
  • Parathyroidectomy (methods)
  • Predictive Value of Tests
  • Radiopharmaceuticals
  • Retrospective Studies
  • Sensitivity and Specificity
  • Technetium Tc 99m Sestamibi
  • Tomography, Emission-Computed, Single-Photon
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: